secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001104659-25-067785
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Shaheen Wirk resigns from Tvardi Therapeutics board, no disagreement cited
--------------------------------------------------------------------------------

- Shaheen Wirk resigned from the Board of Directors on July 8, 2025.
- Resignation was not the result of any disagreement with the company.
- Wirk had served as a board member since March 2024 and previously as a special advisor.
- No replacement has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925067785/0001104659-25-067785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925067785/tm2520679d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-067785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer